middle.news
How Is Imagion Biosystems Revolutionising HER2 Breast Cancer Imaging with AI and Manufacturing Breakthroughs?
9:27am on Monday 8th of September, 2025 AEST
•
Healthcare
Read Story
How Is Imagion Biosystems Revolutionising HER2 Breast Cancer Imaging with AI and Manufacturing Breakthroughs?
9:27am on Monday 8th of September, 2025 AEST
Key Points
Manufacturing of MagSense® HER2 imaging agent commenced for Phase 2 trial
Dr Nina Webster appointed as Non-Executive Director to strengthen board expertise
AI imaging protocol collaboration underway with Wayne State University and Siemens Healthineers
IND application preparation progressing with FDA engagement planned for Q4 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE